StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) PT Raised to $53 at Cantor Fitzgerald
October 17, 2018 9:06 AM
Cantor Fitzgerald analyst Louise Chen raised the price target on Pfizer (NYSE: PFE) to $53.00 (from $45.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
BioMarin Pharma (BMRN) Announces $15M Milestone Payment from Pfizer (PFE)
October 16, 2018 12:59 PM
FDA approves Pfizer's (PFE) talazoparib for gBRCAm HER2-negative locally advanced or metastatic breast cancer
October 16, 2018 11:28 AM
U.S. to propose TV ads for drugs must include list prices
October 15, 2018 1:37 PM